While the Federal Government Twiddles its Thumbs, States Take Action on Reining in Drug Prices

by KJ McElrath | Mar 15, 2018 | Pharmaceutical Industry |

On the issue of out-of-control drug pricing, the federal government has been all talk and...

Another Fox to Guard the Henhouse: Meet HHS Nominee Alex Azar

by KJ McElrath | Dec 4, 2017 | Pharmaceutical Industry |

Back in October, Donald “I’m Gonna to Drain the Swamp” Trump used his favorite metaphor,...

Scientists Discover Another Long-Term Consequence of Excessive Antibiotic Use

by KJ McElrath | Nov 29, 2017 | Pharmaceutical Industry |

The rise in antibiotic-resistant infections caused by “superbugs” has been widely reported in...

“Avatar Therapy” – Another Non-Drug Treatment for Schizophrenia

by KJ McElrath | Nov 24, 2017 | Pharmaceutical Industry |

Big Pharma may not like the results of a study that came out of the UK this week – but it is good...

Big Pharma’s Price Gouging – it’s Not Just in the U.S.

by KJ McElrath | Nov 22, 2017 | Pharmaceutical Industry |

Price gouging – charging obscene markups on life-saving medications affects more than just U.S....

Taking Zostavax For Shingles? The CDC Says You Should Take Something Different

by KJ McElrath | Nov 20, 2017 | Pharmaceutical Industry |

Earlier this year, plaintiffs who took a vaccine for shingles, known as Zostavax, began filing...